The estimated Net Worth of Christopher J Neugent is at least 215 千$ dollars as of 12 May 2021. Mr. Neugent owns over 15,000 units of Calyxt Inc stock worth over 94,500$ and over the last 9 years he sold CLXT stock worth over 0$. In addition, he makes 120,983$ as Independent Director at Calyxt Inc.
Sign up
Mr. Neugent CLXT stock SEC Form 4 insiders trading
Christopher has made over 1 trades of the Calyxt Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of CLXT stock worth 59,250$ on 12 May 2021.
The largest trade he's ever made was buying 15,000 units of Calyxt Inc stock on 12 May 2021 worth over 59,250$. On average, Christopher trades about 1,154 units every 0 days since 2015. As of 12 May 2021 he still owns at least 15,000 units of Calyxt Inc stock.
You can see the complete history of Mr. Neugent stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Neugent biography
Christopher J. Neugent serves as Independent Director of the Company. Mr. Neugent, has served as a member of our Board since September 2018. Mr. Neugent has served as the Executive Vice President of Strategy of Post Holdings, Inc. (NYSE: POST), which is a $6.0 billion holding company with six operating divisions, since July 2018. Prior to this, he served as President and CEO of Post Consumer Brands from its founding in November 2015 until July 2018. Previously, Mr. Neugent held various leadership roles at MOM Brands Company beginning in 2001. He served as the President and Chief Executive Officer of MOM Brands Company beginning in 2008, and also assumed the responsibilities of Chairman of the Board in 2011. Mr. Neugent held these roles until Post acquired MOM Brands Company in 2015. Mr. Neugent has served on the Board of Welch Foods, Inc. since February 2016. He holds a Bachelor of Arts degree in economics from Princeton University and completed the Advanced Management Program at the Wharton School of Business.
What is the salary of Christopher Neugent?
As the Independent Director of Calyxt Inc, the total compensation of Christopher Neugent at Calyxt Inc is 120,983$. There are 9 executives at Calyxt Inc getting paid more, with James Blome having the highest compensation of 4,488,350$.
How old is Christopher Neugent?
Christopher Neugent is 59, he's been the Independent Director of Calyxt Inc since 2018. There are 2 older and 13 younger executives at Calyxt Inc. The oldest executive at Calyxt Inc is Philippe Dumont, 68, who is the Independent Director.
What's Christopher Neugent's mailing address?
Christopher's mailing address filed with the SEC is Mount Ridge Road, Roseville, Ramsey County, Minnesota, 55113-5499, United States.
Insiders trading at Calyxt Inc
Over the last 7 years, insiders at Calyxt Inc have traded over 2,578,214$ worth of Calyxt Inc stock and bought 116,475 units worth 1,447,167$ . The most active insiders traders include Kimberly K. Nelson、Daniel F Voytas、Yves J Ribeill. On average, Calyxt Inc executives and independent directors trade stock every 23 days with the average trade being worth of 35,853$. The most recent stock trade was executed by Yves J Ribeill on 19 September 2022, trading 30,000 units of CLXT stock currently worth 7,200$.
What does Calyxt Inc's logo look like?
Complete history of Mr. Neugent stock trades at Post Inc、Calyxt Inc
Calyxt Inc executives and stock owners
Calyxt Inc executives and other stock owners filed with the SEC include:
-
James Blome,
Chief Executive Officer, Director -
William Koschak,
Chief Financial Officer -
Debra Frimerman,
General Counsel -
Kimberly Nelson,
Independent Director -
William F. Koschak,
Chief Financial Officer -
Dr. Travis J. Frey Ph.D.,
Chief Technology Officer -
Daniel Voytas,
Chief Scientific Officer -
Philippe Dumont,
Independent Director -
Yves Ribeill,
Chairman of the Board -
Christopher Neugent,
Independent Director -
Anna Kozicz-Stankiewicz,
Independent Director -
Jonathan Fassberg,
Independent Director -
Chris Tyson,
IR Contact Officer -
Laurent Arthaud,
Director -
Bobby Williams,
Director - Gene Editing -
Vince Restucci,
Vice President of Agronomy Services -
Sarah Reiter,
Vice President - Business Development -
Travis Frey,
Chief Technology Officer -
Keith Blanks,
Senior Vice President of Sales and Marketing -
Gerry Nuovo,
Sr. VP of Bus. Devel. -
Dr. Stephen M. Bravo,
Chief Medical Officer -
Trina Lundblad,
Director of Communications -
Debra H. Frimerman,
Gen. Counsel & Corp. Sec. -
Dr. Daniel F. Voytas Ph.D.,
Founder, Chief Science Officer & Chair of Scientific Advisory Board -
Michael Allen Carr,
Pres, CEO & Director -
Michael A. Carr,
President and CEO -
Manoj Sahoo,
Chief Commercial Officer -
Alain Godard,
Director -
Bryan W.J. Corkal,
Chief Financial Officer -
Michel Arbadji,
Director of Business Developme -
Federico A. Tripodi,
Chief Executive Officer -
Glenn R Bowers,
Vice President of Breeding -
S.A. Cellectis,
10% owner